Medindia
Medindia LOGIN REGISTER
Advertisement

12 Hidden Facts About Hemophilia B

Hemophilia B is a rare single gene disorder. It is also known as Factor IX deficiency or Christmas disease. This disorder tends to run in families for generations as it only affects males because it is X- linked disorder (1 Trusted Source
Hemophilia B: Medlineplus

Go to source
).

Due to the deficiency of an important clotting factor called factor IX, blood clot formation following an injury may not be proper, and so following an accident, hemophiliacs can suffer from excessive bleeding, as it takes longer to heal, in comparison to normal individuals.

Advertisement

Facts About Hemophilia B

  1. Hemophilia B is thought to be named after Stephen Christmas, who was first diagnosed with this disease in 1952 (2 Trusted Source
    Factor IX deficiency (Christmas disease)

    Go to source
    ).
  2. Hemophilia B is inherited as an X-linked recessive disorder, where only the males are affected, and females act as carriers of the disease (3 Trusted Source
    Hemophilia B

    Go to source
    ).
  3. Worldwide, Hemophilia B is considered to be seven times less common than Hemophilia A which occurs in about 1 in 25,000 and 1 in 30,000–60,000 boys in the US and India (2 Trusted Source
    Factor IX deficiency (Christmas disease)

    Go to source
    ).
Advertisement
  1. It is estimated that currently, around 30,000 - 33,000 men in the United States are suffering from this disorder (4 Trusted Source
    A New Study of Hemophilia Occurrence Finds Many More Cases in the United States

    Go to source
    ).
  2. In the United States, it is estimated that Hemophilia A is four times more common than Hemophilia B and almost half of those who are affected have a severe form of this disorder (5 Trusted Source
    Evaluation of CDC's Hemophilia Surveillance Program - Universal Data Collection (1998-2011) and Community Counts (2011-2019), United States

    Go to source
    ).
  3. Hemophilia can affect people of all racial and ethnic groups (6 Trusted Source
    What is Hemophilia?

    Go to source
    ).
  4. Hemophilia B is sometimes also referred to as 'The Royal Disease', because it had affected the royal families of England, Germany, Russia and Spain in the 19th and 20th centuries (7 Trusted Source
    Hemophilia - B

    Go to source
    ).
Advertisement
  1. Queen Victoria who ruled England between 1837 and 1901, is said to have been a carrier of Hemophilia B (8 Trusted Source
    Hemophilia

    Go to source
    ).
  2. The global incidence of Hemophilia is estimated to be more than 400,000, and it is estimated that around 75% of people with hemophilia still don’t have access to adequate treatment (9 Trusted Source
    Haemophilia: provision of factors and novel therapies: World Federation of Hemophilia goals and achievements

    Go to source
    ).
  3. There is no cure for the disease, and the standard treatment of factor IX concentrates can be effective to overcome the deficiency.
  4. About one third of hemophilia cases occur in families with no previous history of the disorder (10 Trusted Source
    Clinical and laboratory approaches to hemophilia a

    Go to source
    ).
  5. Hemophilia can occur in women, but it is less common (11 Trusted Source
    Women Can Have Hemophilia, Too

    Go to source
    ).

Advertisement
Last Updated on Mar 06, 2023
Recommended Readings

Hemophilia - Related News

Taking NSAIDs With Blood Thinners Doubles Risk of Internal Bleeding, Study Finds
A new study reveals that combining NSAIDs with blood thinners significantly increases the risk of internal bleeding, urging patients to consult their doctor.
India's Medical Milestone: Gene Therapy Success for Haemophilia A
Integrated gene therapy successfully treated Haemophilia A in India, providing long-term relief without bleeding episodes for over 14 months, signaling a potential cure.
Link Found Between Red Light and Reduced Blood Clot Risk
Studies reveal a connection between red light exposure and a reduced risk of blood clots, offering potential new insights for health and prevention strategies.
New Blood Thinner Reduces Bleeding Risk in Atrial Fibrillation Patients
Researchers have found that Factor XI inhibitors, such as abelacimab, reduce bleeding risks in atrial fibrillation patients more effectively than standard anticoagulants.
Abelacimab Lowers Bleeding Risks in Atrial Fibrillation Patients
Discover how abelacimab reduces bleeding risks in AFib patients by effectively lowering free factor XI levels.
More Related News

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.

Health Facts
View all
Advertisement
What's New on Medindia
6 Beauty Products That Can Damage Your Kidneys
NiMe Diet: Gut-Boosting Revolution for Weight Loss and Health
Winter Yoga: Top 7 Poses to Stay Warm and Energized
View all
Advertisement
Benefits of Registration
Stay Connected
Available on the Android Market Available on the App Store
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close